Clinical Trials · NCT00517283
A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 17
- Start date
- Jan 2005
- Locations
- 1 site, United Kingdom
- Primary endpoint
- To detect the mean difference in half gastric emptying time for a solid meal between any treatment and placebo